An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma

Sabrina Bimonte, Antonio Barbieri, Raffaele Palaia, Maddalena Leongito, Vittorio Albino, Mauro Piccirillo, Claudio Arra, Francesco Izzo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hepatocellular carcinoma is a highly aggressive malignancy and is the third leading cause of cancer-related deaths worldwide. Although surgery is currently considered the most effective curative treatment for this type of cancer, it is note that most of patients have a poor prognosis due to chemioresistence and tumor recurrence. Loco-regional therapies, including radiofrequency ablation, surgical resection and transcatheter arterial chemoembolization play a major role in the clinical management of hepatocellular carcinoma. In order to improve the treatment outcome of patients diagnosed with this disease, several in vivo studies by using different techniques on cancer mouse models have been performed. This review will focus on the latest papers on the efficacy of loco-regional therapy and combined treatments in patients and mouse models of hepatocellular carcinoma.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalInfectious Agents and Cancer
DOIs
Publication statusAccepted/In press - Mar 9 2015

Fingerprint

Hepatocellular Carcinoma
Neoplasms
Therapeutics
Recurrence

Keywords

  • Drug delivery
  • Efficacy
  • Hepatocellular carcinoma
  • Loco-regional treatments
  • Safety

ASJC Scopus subject areas

  • Infectious Diseases
  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma. / Bimonte, Sabrina; Barbieri, Antonio; Palaia, Raffaele; Leongito, Maddalena; Albino, Vittorio; Piccirillo, Mauro; Arra, Claudio; Izzo, Francesco.

In: Infectious Agents and Cancer, 09.03.2015, p. 1-4.

Research output: Contribution to journalArticle

@article{42eeea40cdc040c7a18beb95672ba907,
title = "An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma is a highly aggressive malignancy and is the third leading cause of cancer-related deaths worldwide. Although surgery is currently considered the most effective curative treatment for this type of cancer, it is note that most of patients have a poor prognosis due to chemioresistence and tumor recurrence. Loco-regional therapies, including radiofrequency ablation, surgical resection and transcatheter arterial chemoembolization play a major role in the clinical management of hepatocellular carcinoma. In order to improve the treatment outcome of patients diagnosed with this disease, several in vivo studies by using different techniques on cancer mouse models have been performed. This review will focus on the latest papers on the efficacy of loco-regional therapy and combined treatments in patients and mouse models of hepatocellular carcinoma.",
keywords = "Drug delivery, Efficacy, Hepatocellular carcinoma, Loco-regional treatments, Safety",
author = "Sabrina Bimonte and Antonio Barbieri and Raffaele Palaia and Maddalena Leongito and Vittorio Albino and Mauro Piccirillo and Claudio Arra and Francesco Izzo",
year = "2015",
month = "3",
day = "9",
doi = "10.1186/s13027-015-0004-2",
language = "English",
pages = "1--4",
journal = "Infectious Agents and Cancer",
issn = "1750-9378",
publisher = "BioMed Central",

}

TY - JOUR

T1 - An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma

AU - Bimonte, Sabrina

AU - Barbieri, Antonio

AU - Palaia, Raffaele

AU - Leongito, Maddalena

AU - Albino, Vittorio

AU - Piccirillo, Mauro

AU - Arra, Claudio

AU - Izzo, Francesco

PY - 2015/3/9

Y1 - 2015/3/9

N2 - Hepatocellular carcinoma is a highly aggressive malignancy and is the third leading cause of cancer-related deaths worldwide. Although surgery is currently considered the most effective curative treatment for this type of cancer, it is note that most of patients have a poor prognosis due to chemioresistence and tumor recurrence. Loco-regional therapies, including radiofrequency ablation, surgical resection and transcatheter arterial chemoembolization play a major role in the clinical management of hepatocellular carcinoma. In order to improve the treatment outcome of patients diagnosed with this disease, several in vivo studies by using different techniques on cancer mouse models have been performed. This review will focus on the latest papers on the efficacy of loco-regional therapy and combined treatments in patients and mouse models of hepatocellular carcinoma.

AB - Hepatocellular carcinoma is a highly aggressive malignancy and is the third leading cause of cancer-related deaths worldwide. Although surgery is currently considered the most effective curative treatment for this type of cancer, it is note that most of patients have a poor prognosis due to chemioresistence and tumor recurrence. Loco-regional therapies, including radiofrequency ablation, surgical resection and transcatheter arterial chemoembolization play a major role in the clinical management of hepatocellular carcinoma. In order to improve the treatment outcome of patients diagnosed with this disease, several in vivo studies by using different techniques on cancer mouse models have been performed. This review will focus on the latest papers on the efficacy of loco-regional therapy and combined treatments in patients and mouse models of hepatocellular carcinoma.

KW - Drug delivery

KW - Efficacy

KW - Hepatocellular carcinoma

KW - Loco-regional treatments

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=84928727679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928727679&partnerID=8YFLogxK

U2 - 10.1186/s13027-015-0004-2

DO - 10.1186/s13027-015-0004-2

M3 - Article

AN - SCOPUS:84928727679

SP - 1

EP - 4

JO - Infectious Agents and Cancer

JF - Infectious Agents and Cancer

SN - 1750-9378

ER -